142 results on '"Rushing, Elisabeth Jane"'
Search Results
2. A T-cell antigen atlas for meningioma: novel options for immunotherapy
3. Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET gene
4. Intra-, para-, and suprasellar nuclear protein of testis carcinoma with infiltration of cavernous sinus and clivus—a case report
5. Association of pre- and postoperative αKlotho levels with long-term remission after pituitary surgery for acromegaly
6. A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up
7. Primary Olfactory Neuroblastoma Masquerading as a Pituitary Adenoma: Case Report and Review of the Literature
8. An unexpected intracerebral lesion – case report of a superinfected aspergillosis mimicking a brain metastasis
9. Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non–small Cell Lung Cancer Recurrence
10. Post-operative cardiovascular complications and time to recurrence in meningioma patients treated with versus without pre-operative embolization: a retrospective cohort study of 741 patients
11. 18F-FET PET for Diagnosis of Pseudoprogression of Brain Metastases in Patients With Non–Small Cell Lung Cancer
12. A Prognostic Model For Tumor Recurrence And Progression After Meningioma Surgery: Preselection For Further Molecular Work
13. Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types
14. Anaplastic ganglioglioma—A diagnosis comprising several distinct tumour types
15. Intravascular large B‑cell lymphoma: A rare and potentially reversible cause of cerebral stroke
16. MEDB-04. Young children with metastatic medulloblastoma: frequent requirement for radiotherapy in children with non-WNT/non-SHH medulloblastoma despite highly intensified chemotherapy – Results of the MET-HIT2000-BIS4 trial
17. Neurofibromatosis type 1 (NF1) with an unusually severe phenotype due to digeny for NF1 and ryanodine receptor 1 associated myopathy
18. WITHDRAWN: Molecular characterization and clinical impact of co-occurring mutations in patients with NSCLC harboring genomic alterations of MET.
19. Intra-, para-, and suprasellar nuclear protein of testis carcinoma with infiltration of cavernous sinus and clivus—a case report
20. A 44-Year Old Male with Right-Sided Facial Numbness
21. The molecular evolution of glioblastoma treated by gross total resection alone
22. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen
23. Muscle Magnetic Resonance Imaging of the Lower Limbs: Valuable Diagnostic Tool in the Investigation of Childhood Neuromuscular Disorders
24. Pediatric papillary tumors of the pineal region: to observe or to treat following gross total resection?
25. Blood-brain barrier alterations in human brain tumors revealed by genome-wide transcriptomic profiling
26. Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort
27. MODL-22. DEVELOPING A REAL-TIME PERSONALIZED DRUG TESTING PLATFORM FOR PEDIATRIC CNS CANCERS
28. MBCL-07. NON-METASTATIC MEDULLOBLASTOMA OF EARLY CHILDHOOD: RESULTS FROM THE PROSPECTIVE CLINICAL TRIAL HIT-2000 AND AN EXTENDED VALIDATION COHORT
29. The molecular evolution of glioblastoma treated by gross total resection alone
30. Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort
31. Inflammatory olfactory neuropathy in two patients with Covid-19
32. Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes
33. Venous thromboembolic events in glioblastoma patients: Common complication but not a major reason for death.
34. Single cell mapping of human brain tumors reveals tumor-specific education of tissue-invading leukocytes.
35. Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination
36. 18F-FET PET for Diagnosis of Pseudoprogression of Brain Metastases in Patients With Non–Small Cell Lung Cancer
37. Leitlinie : ICD-10 C71 : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen
38. Leitlinie - ICD-10 C71 : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen
39. Glioblastoma in the era of bevacizumab: An epidemiological study in the Canton of Zurich, Switzerland, 2010-2014.
40. ACTR-05. THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
41. MNGI-02. PREOPERATIVE EMBOLIZATION OF MENINGIOMA: INFERIOR NEUROLOGICAL OUTCOME, INCREASED RISK OF CARDIOVASCULAR COMPLICATIONS AND SHORTER TIME TO RECURRENCE?
42. CMET-26. DIAGNOSTIC VALUE OF FDG-PET/CT FOR PATIENTS WITH BRAIN METASTASIS FROM UNKNOWN PRIMARY SITE
43. Glioblastoma in the canton of Zurich, Switzerland revisited: 2005 to 2009
44. Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009
45. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: Efficacy and imaging analyses of the ARTE trial.
46. The value of 18F-fluordesoxyglucose positron emission tomography (FDG-PET/CT) in the detection of the primary lesion and for staging in brain metastasis (BM) patients with cancer of unknown primary site (CUPS).
47. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein
48. A 44-year old male with right-sided facial numbness. Dura-associated extranodal marginal zone B cell lymphoma (MALT lymphoma)
49. A 44‐Year Old Male with Right‐Sided Facial Numbness
50. Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.